AI filing briefs · archive

8-K filings in February 2024, explained

149 material Form 8-K filings that 134 companies we cover made with the SEC in February 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

9 of 149 briefs match

newest first · times in ET
ARLOArlo Technologies, Inc. Feb 29, 4:30 PM ET

Arlo names CFO Kurt Binder also Chief Operating Officer, effective February 28, 2024

Neutral leadership Written later 5.02

Arlo Technologies appointed Chief Financial Officer Kurt Binder as its Chief Operating Officer, effective February 28, 2024, adding the role to his existing CFO duties. He received a performance-vesting award of 600,000 RSUs tied to growth in cumulative paid subscribers, which would dilute shareholders only if the milestones are reached.

  • Kurt Binder, 53, named Chief Operating Officer effective February 28, 2024; he remains CFO, a role he has held since September 26, 2022.
  • Board committee approved the appointment on February 2, 2024; the company announced it February 29, 2024.
  • Award of 600,000 performance-vesting RSUs, vesting in three equal installments at 1, 2 and 3 million incremental Cumulative Paid Subscribers over audited year-end 2023 levels, with a five-year deadline per level.
  • Binder previously was CFO of CalAmp Corp. and CFO of VIZIO, Inc.
Read the filing on SEC.gov ↗
LIFLife360, Inc. Feb 29, 4:24 PM ET

Life360 reports 2023 revenue of $305 million and narrower net loss of $28.2 million

Positive earnings Written later 2.027.01

Life360 reported 2023 revenue of $305 million, up 33% year over year, and a net loss of $28.2 million, down from $91.6 million in 2022. Adjusted EBITDA was $20.6 million, compared with negative $40.1 million a year earlier, and the company said it was its first full year of positive Adjusted EBITDA. For 2024, it guided to consolidated revenue of $365 million to $375 million and Adjusted EBITDA of $30 million to $35 million, and it announced a new advertising revenue stream.

  • 2023 revenue of $305 million, up 33% year over year; company said this was in line with its guidance of $300 million to $310 million
  • Net loss of $28.2 million in 2023, an improvement of $63.5 million from 2022
  • Adjusted EBITDA of $20.6 million in 2023, versus negative $40.1 million in 2022
  • 2024 guidance: revenue of $365 million to $375 million, Adjusted EBITDA of $30 million to $35 million, and year-end cash of $80 million to $90 million
Read the filing on SEC.gov ↗
BFSSAUL CENTERS, INC. Feb 29, 4:21 PM ET

Saul Centers Q4 revenue rises to $66.7 million; EPS $0.43 vs. $0.38 a year earlier

Positive earnings Written later 2.02

Saul Centers reported fourth-quarter 2023 results on February 29, 2024, with total revenue up to $66.7 million from $62.3 million and net income available to common stockholders of $10.4 million, or $0.43 per share, versus $9.1 million, or $0.38, a year earlier. Diluted FFO per share was $0.79 compared with $0.72, and the filing shows the gains came mainly from higher termination fees and base rent.

  • Q4 2023 total revenue rose to $66.7 million from $62.3 million; net income rose to $17.5 million from $15.4 million.
  • Net income available to common stockholders was $10.4 million ($0.43 per basic and diluted share) vs. $9.1 million ($0.38) in Q4 2022.
  • Diluted FFO per share was $0.79 vs. $0.72; full-year 2023 diluted FFO per share was $3.12 vs. $3.04.
  • Same property operating income rose 8.8% in the quarter; commercial portfolio 94.2% leased at December 31, 2023 vs. 93.2%.
Read the filing on SEC.gov ↗
INVAInnoviva, Inc. Feb 29, 4:15 PM ET

Innoviva swings to $61.5 million Q4 2023 net income; full-year profit falls

Mixed earnings Written later 2.02

Innoviva reported fourth-quarter 2023 total revenue of $85.8 million, up from $65.8 million a year earlier, and net income of $61.5 million, compared with a net loss of $68.3 million in the fourth quarter of 2022. For the full year, total revenue fell to $310.5 million from $331.3 million and net income fell to $179.7 million from $213.9 million, so shareholders see a strong quarter within a weaker year.

  • Q4 2023 total revenue was $85.8 million, versus $65.8 million in Q4 2022.
  • Q4 2023 net income was $61.5 million, or $0.97 basic per share, versus a net loss of $68.3 million, or $(0.98) per share, a year earlier.
  • Full-year 2023 net income was $179.7 million, or $2.75 basic per share, versus $213.9 million, or $3.07 per share, in 2022.
  • In Q4 2023 Innoviva repurchased 1,121,835 shares for $15.4 million.
Read the filing on SEC.gov ↗
ARLOArlo Technologies, Inc. Feb 29, 4:10 PM ET

Arlo Q4 revenue rises 14% to $135.1 million; GAAP EPS turns positive at $0.01

Positive earnings Written later 2.02

Arlo Technologies reported fourth-quarter 2023 revenue of $135.1 million, up 14.0% year over year, and GAAP net earnings of $0.01 per diluted share, compared with a loss of $0.25 a year earlier. For the full year, revenue was $491.2 million and GAAP net loss per share narrowed to $(0.24) from $(0.65). The company also gave first-quarter 2024 revenue guidance of $117 million to $127 million.

  • Q4 2023 revenue of $135.1 million, up 14.0% year over year; service revenue of $55.9 million, up 45.9%
  • Q4 2023 GAAP EPS of $0.01 and non-GAAP EPS of $0.11, versus GAAP loss of $(0.25) in Q4 2022
  • FY2023 revenue of $491.2 million, a slight increase; GAAP net loss per share of $(0.24) versus $(0.65) in 2022
  • Q1 2024 outlook: revenue of $117 million to $127 million; GAAP EPS of $(0.08) to $(0.02)
Read the filing on SEC.gov ↗

California Water Service Group: 2023 net income falls to $51.9 million

Negative earnings Written later 2.02

California Water Service Group reported 2023 net income attributable to the company of $51.9 million, or $0.91 per diluted share, down from $96.0 million, or $1.77 per share, in 2022. The company attributed the decline primarily to the delayed final decision from the California Public Utilities Commission on its pending 2021 General Rate Case, and said it cannot reasonably estimate the impact on 2023 revenue and expenses until that decision is made.

  • Full-year 2023 operating revenue was $794.6 million, down $51.8 million from $846.4 million in 2022.
  • Fourth-quarter 2023 net income attributable to the company was $30.1 million, or $0.52 per diluted share, versus $19.6 million, or $0.35, in the fourth quarter of 2022.
  • On January 24, 2024, CPUC administrative law judges issued a Proposed Decision and a commissioner issued an Alternate Proposed Decision on the 2021 General Rate Case; the company cannot determine which will be adopted.
  • The Board increased the quarterly cash dividend by 7.7% to $0.28 per share on January 25, 2024.
Read the filing on SEC.gov ↗
ICUIICU MEDICAL INC/DE Feb 29, 8:32 AM ET

ICU Medical director William Seeger resigns from board, effective immediately

Neutral leadership Written later 5.02

William Seeger, a director of ICU Medical, resigned from the company's board and its Audit and Compliance Committee effective immediately, as Smiths Group's nominated director, in anticipation of his retirement from the Smiths Group board on May 31, 2024. The filing states the resignation did not result from any disagreement with the company or any matter relating to its operations, policies or practices, and that Smiths Group keeps the right to designate a board member while it owns at least 5% of the company's common stock.

  • William Seeger resigned from the ICU Medical board and Audit and Compliance Committee, effective immediately
  • Seeger's resignation is tied to his planned retirement from the Smiths Group plc board on May 31, 2024
  • The filing states no disagreement with the company or matter relating to its operations, policies or practices
  • Smiths Group may keep designating a board member while it owns at least 5% of ICU Medical common stock, per the January 6, 2022 Shareholders Agreement
Read the filing on SEC.gov ↗
VCELVericel Corp Feb 29, 8:04 AM ET

Vericel Q4 revenue rises 23% to $65.0 million; 2024 revenue guidance $237-$241 million

Positive earnings Written later 2.02

Vericel reported fourth-quarter and full-year 2023 results, with total revenue up 23% to $65.0 million in the quarter and up 20% to $197.5 million for the year. The company also issued 2024 guidance calling for total net revenue of $237 to $241 million, a gross margin of approximately 70%, and an adjusted EBITDA margin of approximately 20%. Shareholders get a view of stronger quarterly profit and a narrower full-year net loss, along with the company's first full-year revenue outlook in this release.

  • Q4 2023 net income was $13.0 million, or $0.26 per diluted share, versus $5.9 million, or $0.12 per diluted share, in Q4 2022.
  • Full-year 2023 net loss was $3.2 million, or $0.07 per diluted share, compared with a net loss of $16.7 million, or $0.35 per diluted share, in 2022.
  • MACI net revenue was $164.8 million for 2023, up 25%; Burn Care net revenue was $32.7 million.
  • As of December 31, 2023, the company had $152.6 million in cash, restricted cash and investments and no debt.
Read the filing on SEC.gov ↗
STRAStrategic Education, Inc. Feb 29, 6:36 AM ET

Strategic Education Q4 revenue rises 12.1% to $302.7 million; diluted EPS $1.63

Positive earnings Written later 2.02

Strategic Education reported fourth-quarter 2023 revenue of $302.7 million, up 12.1% from a year earlier, and diluted earnings per share of $1.63 versus $0.77. Net income for the quarter was $39.1 million, compared with $18.3 million in the fourth quarter of 2022. The company also declared a regular quarterly dividend of $0.60 per share.

  • Q4 2023 revenue rose 12.1% to $302.7 million; net income was $39.1 million versus $18.3 million
  • Diluted EPS was $1.63 versus $0.77; adjusted diluted EPS was $1.68 versus $0.78 (non-GAAP)
  • Full-year 2023 revenue rose 6.3% to $1.13 billion; full-year diluted EPS was $2.91 versus $1.94
  • Quarterly dividend of $0.60 per share is payable March 18, 2024 to holders of record as of March 11, 2024
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.